Premium
Evidence‐based medicine in cystic fibrosis: How should practice change?
Author(s) -
Conway Steven P.
Publication year - 2002
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.10137
Subject(s) - medicine , cystic fibrosis , intensive care medicine , life expectancy , quality of life (healthcare) , diabetes mellitus , intervention (counseling) , pediatrics , clinical practice , family medicine , nursing , endocrinology , population , environmental health
This critical review of current practice and research in some aspects of cystic fibrosis (CF) concludes that, despite recent success in prolonging life expectancy, there is still room for improvement in terms of earlier diagnosis and earlier intervention in some of its complications. Specifically, the body of evidence implies that neonatal diagnosis; early attention to nutrition, staphylococcal and pseudomonal infection, and diabetes mellitus; and early treatment with dornase alfa can all be expected to improve patients' quality and quantity of life. Pediatr Pulmonol. 2002; 34:242–247. © 2002 Wiley‐Liss, Inc.